NCT06977048

Brief Summary

This study was designed to evaluate the effect of education delivered through an animation-based mobile application on the knowledge level, self-efficacy, wound size, and metabolic parameters of individuals with diabetic foot ulcers.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 30, 2025

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 1, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 16, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
24 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2025

Completed
Last Updated

May 16, 2025

Status Verified

April 1, 2025

Enrollment Period

7 months

First QC Date

May 1, 2025

Last Update Submit

May 10, 2025

Conditions

Keywords

diabetic footanimation

Outcome Measures

Primary Outcomes (3)

  • Change in Diabetic Foot Ulcer Size (cm²)

    This outcome measures the change in the surface area (cm²) of the diabetic foot ulcer from baseline (Week 0) to the end of the intervention (Week 12). The wound size is calculated using the formula length × width (cm × cm).

    aseline (Week 0) Follow-up (Week 12) (Optional intermediate check at Week 8)

  • The Diabetic Foot Care Self-Efficacy Scale (DFCSES)

    The Diabetic Foot Care Self-Efficacy Scale (DFCSES), originally developed by Quarles (2005) and adapted into Turkish by Kır Biçer (2011), will be used to assess participants' self-efficacy regarding diabetic foot care. The scale consists of 9 items rated on a scale from 0 (not confident at all) to 10 (completely confident), with total scores ranging from 0 to 90. Higher scores reflect greater self-efficacy in diabetic foot care. The change in total score from baseline to 12 weeks post-intervention will be evaluated.

    Baseline (Week 0) Follow-up (Week 12)

  • Change in Diabetic Foot Knowledge Score

    Knowledge of diabetic foot care will be measured using a 5-item subscale from the Diabetes Knowledge Questionnaire-24 (DKQ-24), originally developed by Garcia et al. and adapted into Turkish by Biçer. Each item is answered as "Yes," "No," or "I don't know." Total scores range from 0 to 5, with higher scores reflecting greater knowledge of diabetic foot care. The change in score from baseline to 12 weeks post-intervention will be assessed.

    Baseline (Week 0) Follow-up (Week 12)

Secondary Outcomes (7)

  • Change in HbA1c (%)

    Baseline (Week 0) Follow-up (Week 12)

  • Change in Fasting Blood Glucose (mg/dL)

    Baseline (Week 0) Follow-up (Week 12)

  • Change in Triglycerides (mg/dL)

    Baseline (Week 0) Follow-up (Week 12)

  • Change in HDL Cholesterol (mg/dL)

    Baseline (Week 0) Follow-up (Week 12)

  • Change in LDL Cholesterol (mg/dL)

    Baseline (Week 0) Follow-up (Week 12)

  • +2 more secondary outcomes

Study Arms (2)

Experimental - Mobile Application-Based Education Group (Intervention Group)

OTHER

Participants receive an educational intervention via a mobile application with animation-based videos and modules on diabetic foot ulcer (DFU) care. The intervention spans 12 weeks and includes initial training and weekly follow-ups.

Other: Mobile Application-Based Educational Program

No Intervention - Control Group

OTHER

Participants in this group receive no educational intervention and continue their usual care.

Other: Standard care

Interventions

Week 0: Participants are informed about the study and trained in the use of the mobile application. The mobile app is installed on their smartphones. Educational animation videos and modules are watched with the researcher in a predefined order. Questions about animations are answered. Videos are downloaded to the participant's phone. DFU photographs are recorded. Weeks 1-12: Participants are instructed to use the app regularly between weeks 5-12. Video watching days and durations are logged using a tracking form. Weekly push notifications remind participants to use the app. Weekly phone calls are made to assess engagement using a structured checklist. DFU photographs are taken at weeks 8 and 12. At week 12, data are collected in person, including: DFU size (length × width) with disposable paper ruler Metabolic parameters from blood tests Wagner-Meggitt classification Re-ulceration assessment

Experimental - Mobile Application-Based Education Group (Intervention Group)

Participants provide consent and receive baseline information. DFU photographs are taken at baseline, week 8, and week 12. At week 12, the same outcome measures as the intervention group are collected. After the study ends, participants are provided with access to the mobile application.

No Intervention - Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having a diagnosis of diabetic foot ulcer, having stage 1-2 diabetic foot ulcer according to Wagner classification system, being between the ages of 18-65, being literate, having and using a mobile phone with IOS and ANDROID operating system, volunteering to participate in the study

You may not qualify if:

  • Users who want to withdraw from the research, the patient's exitus during the research process, users who do not log in to the mobile application once a week during the implementation process of the research (twelve weeks) will be excluded from the research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gülhane Training and Research Hospital, University of Health Sciences, Turkey

Ankara, Keçiören, 06300, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetic Foot

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic Neuropathies

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Ayla D Demirtaş

    Saglik Bilimleri Universitesi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Patients will be divided into intervention and control groups by simple randomisation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PHD student

Study Record Dates

First Submitted

May 1, 2025

First Posted

May 16, 2025

Study Start

April 30, 2025

Primary Completion

December 1, 2025

Study Completion

December 25, 2025

Last Updated

May 16, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

The individual participant data (IPD) will not be shared due to ethical concerns and institutional policy restrictions. The collected data include sensitive health information that cannot be anonymized adequately to protect participant privacy.

Locations